Literature DB >> 7678305

B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.

J P Langeveld1, J I Casal, C Vela, K Dalsgaard, S H Smale, W C Puijk, R H Meloen.   

Abstract

Ten antigenic sites on canine parvovirus (CPV) were mapped with a complete set of overlapping nonapeptides of the capsid proteins VP1 and VP2: five of these sites were recognized by sera from CPV-infected dogs, three were recognized by a rabbit anti-CPV antiserum, and two were recognized by murine monoclonal anti-CPV antibodies. A region covering the first 21 amino-terminal amino acid residues of VP2 was recognized by three sera from infected dogs, one neutralizing rabbit antiserum, and one neutralizing murine monoclonal antibody. Immunoabsorption experiments with full virions indicated that at least 6 of the 10 antigenic sites are located on the surface. Of these six, three sites occur in the amino terminus of VP2. When superimposed on the three-dimensional structure of canine parvovirus (J. Tsao, M. S. Chapman, M. Agbandje, W. Keller, K. Smith, H. Wu, M. Luo, T. J. Smith, M. G. Rossmann, R. W. Compans, and C. R. Parrish, Science 251:1456-1464, 1991), the other three epitopes are located on two loops of VP2 which form the highly exposed "spike" around the threefold-symmetry axis of the virus. Thus, these regions (amino terminus and loops 1 and 3) are of interest as major target sites for induction of neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678305      PMCID: PMC237429     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Prediction of beta-turns.

Authors:  P Y Chou; G D Fasman
Journal:  Biophys J       Date:  1979-06       Impact factor: 4.033

2.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  Nature       Date:  1983 Aug 25-31       Impact factor: 49.962

3.  Canine parvovirus: a biochemical and ultrastructural characterization.

Authors:  P R Paradiso; S L Rhode; I I Singer
Journal:  J Gen Virol       Date:  1982-09       Impact factor: 3.891

4.  Canine parvovirus: relationship to wild-type and vaccine strains of feline panleukopenia virus and mink enteritis virus.

Authors:  J D Tratschin; G K McMaster; G Kronauer; G Siegl
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

5.  Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies.

Authors:  C R Parrish; L E Carmichael; D F Antczak
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response.

Authors:  L E Carmichael; J C Joubert; R V Pollock
Journal:  Cornell Vet       Date:  1981-10

7.  A modified live canine parvovirus vaccine. II. Immune response.

Authors:  L E Carmichael; J C Joubert; R V Pollock
Journal:  Cornell Vet       Date:  1983-01

8.  Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.

Authors:  R V Pollock; L E Carmichael
Journal:  J Am Vet Med Assoc       Date:  1982-01-01       Impact factor: 1.936

9.  Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.

Authors:  R V Pollock; L E Carmichael
Journal:  Cornell Vet       Date:  1982-01

10.  Studies on canine parvovirus infections: development of an inactivated vaccine.

Authors:  A K Eugster
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

View more
  28 in total

1.  Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure.

Authors:  M Moskalenko; L Chen; M van Roey; B A Donahue; R O Snyder; J G McArthur; S D Patel
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus.

Authors:  J J Meulenberg; A P van Nieuwstadt; A van Essen-Zandbergen; J P Langeveld
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Parvovirus diagnostics and vaccine production in insect cells.

Authors:  J I Casal
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Sequence analysis of VP2 gene of canine parvovirus isolates in Thailand.

Authors:  Siriwadee Phromnoi; Kaitkanoke Sirinarumitr; Theerapol Sirinarumitr
Journal:  Virus Genes       Date:  2010-03-30       Impact factor: 2.332

5.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

6.  Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence.

Authors:  J I Casal; J P Langeveld; E Cortés; W W Schaaper; E van Dijk; C Vela; S Kamstrup; R H Meloen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors:  J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles.

Authors:  A Hurtado; P Rueda; J Nowicky; J Sarraseca; J I Casal
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.

Authors:  M E Bloom; S M Best; S F Hayes; R D Wells; J B Wolfinbarger; R McKenna; M Agbandje-McKenna
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  The epitope of the VP1 protein of porcine parvovirus.

Authors:  Hong-ling Xie; Zhao Wang; Shang-jin Cui; Chao-fan Zhang; Yu-dong Cui
Journal:  Virol J       Date:  2010-07-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.